17:20 | 06.11.13 | News | 3619

Neonatal care equipment provided to Sisian Maternity House

VivaCell-MTS General Manager Ralph Yirikian and Director of BirthLink Kathy Mellor visited the maternity department in the Medical Center of Sisian.

Due to the location of this hospital it is essential that the health care providers are able to manage emergencies with newborn babies, including prematurity cases. Equipment essential for immediate care and stabilization for these babies should always be available, as in every hospital where deliveries are taking place.

“Availability of high-quality specialists is crucial in saving human lives. However, the willingness to provide high-quality service is directly connected with the special tool and equipment available to a specialist, in order for the latter to be able to fully utilize his skills. Modern equipment guarantees effectiveness of the made efforts. VivaCell-MTS also strives to support medical specialists in all possible ways envisioning the best results,” says VivaCell-MTS General Manager Ralph Yirikian.

This hospital has received equipment for immediate reanimation and warming of sick and small babies, monitoring and management of respiratory difficulties and the provision of intravenous fluids.

This is now the 6th year of co-operation between BirthLink and VivaCell-MTS, to improve the care of sick and premature babies in Armenia, and thereby reduce neonatal mortality.

4 million babies die in the first month of life throughout the world, with three quarters of these deaths in the first week, and more than one million on the first day of life. The program with VivaCell-MTS concentrates on the first day of life, to ensure each maternity facility has the right knowledge and equipment to prevent some of these deaths.

Equipment has been provided to support sick and low birth weight babies after delivery, with provision to stabilize babies before transfer to Yerevan or regional centers. By improving facilities, transfer of some babies can be avoided. In addition to the equipment being provided, education, training and support continues.

In total, VivaCell-MTS allocated 465 million drams for the implementation of long-term program in neonatal care.